Diagnosis of Hexosaminidase a Deficiency with Sulphated Substrate: Evidence for an alpha-Locus Genetic Compound in a Tay-Sachs Variant
- 1 January 1988
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- G m2-gangliosidosis variant with altered substrate specificity: evidence for α-locus genetic compoundJournal of Inherited Metabolic Disease, 1987
- Intermediate forms of human β-N-acetylhexosaminidase lack activity towards 4-methylumbelliferyl β-N-acetylglucosaminide 6-sulphateBiochemical Journal, 1987
- Late onset GM2 gangliosidosis: an α‐locus genetic compound with near normal hexosaminidase activityClinical Genetics, 1985
- Synthesis of and its use in classification of GM2 gangliosidosis genotypesClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Usefulness of 4‐methylumbelliferyl‐6‐ sulfo‐2‐acetamido‐2‐deoxy‐β‐D‐glucopyranoside for the diagnosis of GM2 gangliosidoses in leukocytesClinical Genetics, 1984
- Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. residual activities toward natural and different synthetic substratesHuman Genetics, 1984
- Tay-Sachs disease: one-step assay of β-N-acetylhexosaminidase in serum with a sulphated chromogenic substrateClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- A new variant of Type-AB GM2-gangliosidosisBiochemical and Biophysical Research Communications, 1981
- AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.Proceedings of the National Academy of Sciences, 1978
- Studies on human N-acetyl-β-d-hexosaminidase C separated from neonatal brainBiochemical Journal, 1976